C12Y 204/01222
O-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase
Official title: O-Fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (2.4.1.222)
C12Y204/01222 (O-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase) appears on 2 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 8
- Assignees
- 3
- Inventors
- 17
- Latest grant
- 5 Apr 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- New sialyltransferases for in vivo synthesis of lst-c10 Sep 2026US 2026/0265709 A1
- New sialyltransferases for in vivo synthesis of lst-a25 Sep 2025US 2025/0297296 A1
- Methods of producting hmo blend profiles with lnfp-1 and 2'-fl as the predominant compounds3 Oct 2024US 2024/0327885 A1
- Methods of producing hmo blend profiles with lnfp-i and lnt as the predominant compounds3 Oct 2024US 2024/0327886 A1
- Cellular production of glycosylated products14 Mar 2024US 2024/0084347 A1Inbiose N.V.
Most cited
By later US patents